Mesalamine is a generic drug prescribed for ulcerative colitis. It’s available in several brand-name versions. The cost of mesalamine, with and without insurance, can depend on various factors ...

(Nasdaq: AMRX) ("Amneal" or the "Company"), a global biopharmaceutical company, today announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the ...

Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment of moderately active ulcerative colitis in adults.